Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-19-040632
Filing Date
2019-08-19
Accepted
2019-08-19 16:06:47
Documents
3
Group Members
DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv527942_sc13g.htm SC 13G 46637
2 EXHIBIT 1 tv527942_ex1.htm EX-99.1 5697
3 EXHIBIT 2 tv527942_ex2.htm EX-99.2 4856
  Complete submission text file 0001144204-19-040632.txt   58850
Mailing Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036
Business Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036 2124780000
D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

EIN.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86488 | Film No.: 191036515
SIC: 2834 Pharmaceutical Preparations